top of page

FOST Switch
EVALUATING EFFICACY AND CONVENIENCE OF SWITCHING A BOOSTED PROTEASE INHIBITOR TO FOSTEMSAVIR IN PLWH WITH LIMITED THERAPEUTIC OPTIONS
Status: Ongoing, Open to Recruitment
SPONSOR: NEAT ID Foundation
Funded by: ViiV
Territories : UK, Italy, Spain
Publications: Poster Presentation, BHIVA 2025.
Title: Switching boosted protease inhibitor based antiretroviral therapy to fostemsavir + optimized background regimen in virally suppressed people with HIV with limited therapeutic options

bottom of page